NCT02928601View on ClinicalTrials.gov

Norepinephrine Consumption After Prophylactic Ondansetron

PHASE4CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

August 31, 2017

Study Completion Date

August 31, 2017

Conditions
Maternal Hypotension
Interventions
DRUG

Ondansetron

After spinal anesthesia, half of the patients will be given intravenous 8 mg ondansetron.

DRUG

Saline

After spinal anesthesia, half of the patients will be given intravenous 2 mlt saline.

Trial Locations (1)

01330

Çukurova University, Adana

All Listed Sponsors
lead

Cukurova University

OTHER

NCT02928601 - Norepinephrine Consumption After Prophylactic Ondansetron | Biotech Hunter | Biotech Hunter